Wednesday 13th December 2017
|Text too small?|
Ebos Group chief executive Patrick Davies has stepped down and will be replaced by chief financial officer John Cullity from March 31 next year, the healthcare and animal products company says.
Davies will work on contract for Ebos "to assist with new and emerging opportunities," the company said. It was his decision to step down, Ebos said.
Davis became CEO in July 2014, having held the top job for six years at Symbion, the pharmaceutical wholesaler and distributor in Australia that Ebos acquired in 2013 for $1.1 billion cash and scrip, a deal which transformed the company and saw profit almost triple in 2014. Symbion’s owner Zuellig Group gained a 40 percent stake in the combined business as a result.
Cullity also joined Ebos in July 2014 after roles at Sigma Pharmaceuticals in Australia and Coca-Cola Co in the US.
Ebos shares last traded at $18.34 and have gained 9.8 percent this year.
No comments yet
NZ shares up, Ryman and A2 gain while Fonterra, Infratil fall
NZ dollar unchanged in local trading as markets watch US developments
Robertson's rocket for Treasury over child poverty modelling error
Green Cross community head Simon Lipscombe leaves to head Compass NZ food service group
Labour signals slow track for most contentious labour law reforms
New spray dryer planned at Waikato Innovation Park as sheep milk ramps up
Euro Corp to defend fair trading charges over steel mesh standards
Fonterra criticises Beingmate after 'extremely disappointing' earnings downgrade
Augusta lines up third property for industrial property fund
Blis cuts annual earnings guidance as impact of tough first half lingers